Showing results (71-80 of 107) with videos related to

Sort By:
Pageof 11
International Journal of Hematology|July 5, 2018
Clinical characteristics of pediatric patients with myeloid sarcoma without bone marrow involvement in JapanTakashi Taga, Toshihiko Imamura, Kentaro Nakashima, et al.
Genes, Chromosomes & Cancer|September 23, 2015
Transcriptional dysregulation of the deleted in colorectal carcinoma gene in multiple myeloma and monoclonal gammopathy of undetermined significanceHisao Nagoshi, Tomohiko Taki, Yoshiaki Chinen, et al.
The Journal of Biological Chemistry|August 1, 2008
Fusion of OTT to BSAC results in aberrant up-regulation of transcriptional activityTaisuke Sawada, Chiharu Nishiyama, Takuma Kishi, et al.
International Journal of Hematology|August 28, 2013
WT1 mutation in pediatric patients with acute myeloid leukemia: a report from the Japanese Childhood AML Cooperative Study GroupHirozumi Sano, Akira Shimada, Ken Tabuchi, et al.
International Journal of Hematology|May 25, 2010
Prognostic significance of the BAALC isoform pattern and CEBPA mutations in pediatric acute myeloid leukemia with normal karyotype: a study by the Japanese Childhood AML Cooperative Study GroupYasuhiro Mizushima, Tomohiko Taki, Akira Shimada, et al.
Cancer Research|August 8, 2012
Frequent PVT1 rearrangement and novel chimeric genes PVT1-NBEA and PVT1-WWOX occur in multiple myeloma with 8q24 abnormalityHisao Nagoshi, Tomohiko Taki, Ichiro Hanamura, et al.
Blood|July 11, 2012
Clinical characteristics and outcome of refractory/relapsed myeloid leukemia in children with Down syndromeTakashi Taga, Akiko Moriya Saito, Kazuko Kudo, et al.
Blood|May 10, 2008
Down-regulation of TCF8 is involved in the leukemogenesis of adult T-cell leukemia/lymphomaTomonori Hidaka, Shingo Nakahata, Kinta Hatakeyama, et al.
Leukemia Research|March 11, 2008
Fully automated and super-rapid system for the detection of JAK2V617F mutationRuriko Tanaka, Junya Kuroda, William Stevenson, et al.
British Journal of Haematology|October 16, 2019
Patients aged less than 3 years with acute myeloid leukaemia characterize a molecularly and clinically distinct subgroupYusuke Hara, Norio Shiba, Genki Yamato, et al.
Pageof 11